Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Benzer Pharmacy Strengthens its 340B Program Through a Partnership with North Caddo Medical Center
  • USA - English


News provided by

Benzer Pharmacy

May 08, 2017, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Vivian, Louisiana (PRWEB) May 08, 2017 -- Benzer Pharmacy, an independent pharmacy has today announced its partnership with North Caddo Medical Center.

The purpose of the partnership is to conveniently offer 340B drugs to vulnerable patient populations throughout the United States.  

North Caddo Medical Center, located on 1000 S., Spruce Street, Vivian, LA was established in 1965.

The medical center offers several services including: cardiopulmonary, lab & blood bank, mental health, acute, rehab, dietary, nutritional, and more. The medical center also offers a rare combination of advanced healthcare capabilities and exceptional care for all the families it serves. 

“Benzer is excited and is looking forward to our new partnership with North Caddo Medical Center,” says Ryan Geoghagan, Benzer Pharmacy 340B Program Director.

“This is a huge opportunity for patients who use North Caddo because they can now also use Benzer Pharmacy for all their medication needs,” he adds.

This is Benzer's second 340B contract after signing its first contract last year with Bliss Healthcare Services.

“Our vision is to maintain a compliant 340B program with the aim of creating opportunities for savings and choosing the right 340B partner is one of Benzer’s priorities.”

Benzer Pharmacy located at 202 South Ave Ste A Vivian, LA 71082 has already begun accepting 340B prescriptions from the medical center.

“Participating in a 340B program offers many benefits for contract pharmacies, including increased store traffic, better access to discounted medications and improved healthcare for patients. Our goal is to become the preferred contracted pharmacy to all the covered entities within this geographical area,” Ryan concludes.

340B program provides an opportunity for community pharmacies to provide additional access to specific patients who need discounted prescription drugs. The program also gives the community pharmacy an opportunity to add a revenue stream to its existing business model and enables it to become further involved with patient care.

340B is a U.S Federal Government program that requires drug manufacturers to provide outpatient drugs to eligible health care organizations/covered entities at significantly reduced prices.

For more information, contact: 340b(at)benzerpharmacy(dot)com

###

ABOUT BENZER PHARMACY
Benzer Pharmacy is a chain of independent retail pharmacies that specializes in specialty drugs and also focuses on medication management programs for people with complex chronic diseases including: Hepatitis, HIV, Multiple Sclerosis (MS), Rheumatoid Arthritis (RA), Dermatological conditions and Gastrointestinal Disorders (GI). 
 
The first Benzer Pharmacy opened in 2009 in Flint, Michigan and has now grown to over 65 locations throughout: Tennessee, Florida, Michigan, Virginia, North Carolina, Texas, Georgia, Nevada, Oklahoma, Iowa, Arkansas, Colorado, Louisiana and California.
 
ACCREDITATIONS
¥ 2016: Utilization Review Accreditation Commission (URAC) accreditation for Specialty Pharmacy
¥ 2015: PCAB compounding accreditation with Accreditation Commission for Health Care (ACHC)
 
ACCOLADES
¥ Tampa Bay’s Top Workplaces (2017)
¥ CFO of the Year Awards (2017): Finalist Large company category.
¥ Business Observer (2016) - Rank 99 out of 500 in the Gulf Coast 500: Top Companies
¥ Florida Fast 50 (2016) - Rank 22 out of 50 in the Tampa Bay’s Fastest Growing Companies.
¥ EY Entrepreneur of the Year, (2016) - Benzer Pharmacy CEO was a Florida Finalist.
¥ Silver Stevie® Award (2016) - CEO wins Executive of the Year in the American Business Award
¥ CFO of the Year Awards (2016): Finalist Large company category.
¥ Chain Drug Review (2016: Rank 54 out of 100 in the Top 100 Chains by Pharmacy Count
¥ Inc. 5000 (2015): Rank 1500 - Fastest growing private company in America.
¥ Florida Fast 100 (2015): Rank 39 out of 100 – Fastest growing private companies in Florida
¥ TBBJ 200 (2015): Rank 67 out of 200 - Tampa Bay’s largest private companies
 
All Benzer Pharmacy medications require a doctor's prescription.  For more information: http://www.benzerpharmacy.com
 
Facebook: https://www.facebook.com/BenzerPharmacy
Linkedin: https://www.linkedin.com/company/benzerpharmacy
Instagram: https://instagram.com/benzer_pharmacy

Emah Madegwa, Benzer Pharmacy, http://www.benzerpharmacy.com, +1 (813) 304-2221 Ext: 104, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.